Category

News

Regenerative medicine products are built via a combination of three elements: living cells, a matrix to support the living cells (i.e. a scaffold), and cell communicators (or signaling systems) to stimulate the cells, and their surrounding environment to grow and develop into new tissue.

These are special cells in the body that can turn into other types of cells. During the healing process, regenerative cells are called to the area of the body that needs repair. Factors in the area influence the regenerative cells to become repair cells.

Interestingly, the same regenerative cells that repair bone can also repair muscle, tendon, ligament, or cartilage. Of all of the types of cells, regenerative cells have the greatest potential to promote healing.

Regenerative cells are undifferentiated cells found in bone marrow that have the capacity to become bone, muscle, cartilage, ligament and tendon cells. Upon arrival to the injured tissue, regenerative cells take on the characteristics of that host tissue.

This naturally occurring process is the body’s way of initiating the healing cascade. Because of the dramatic healing capabilities of regenerative cells, BioCellular Therapies has developed concise research and methods that will deliver an increased number of these cells, millions versus thousands, to injured tissue, thereby enhancing the healing process.

Isolating Adult Stem Cells

Using the body’s natural T- Cells for the tissue regenerative property which is highly concentrated in bone marrow. Isolating adult stem cells from a variety of tissues in addition to the blood allows for the ability to create a systematic approach, and specifically crafted treatment plan created specific to each patient.

It is understood that no two people are the same. Hence why we take the time to research and find out every detail of each patient. With our state of the art technology, and research we strive to create the best treatment plan. Upon countless hours of research our doctors do an in depth patient history, and develop the best plan possible for you.

Understanding Adult Stem Cells

ASC stands for adult stem cell. The adult stem cell can renew itself and can differentiate to yield some or all of the major specialized cell types of the tissue or organ. The primary roles of adult stem cells in a living organism are to maintain and repair the tissue in which they are found. This is only found in adults.

Where Are ASCS?

Adult stem cells have been found in the brain, bone marrow, blood vessels, skeletal muscle, and other organs and tissues. They are in specific areas of each tissue, where they may remain dormant for years, dividing and creating new cells only when they are activated by tissue injury, disease or anything else that makes the body need more cells.

How Do We Get ASCS

Adult stem cells can be isolated from the body in different ways, depending on the tissue. Mesenchymal stem cells, which can make bone, cartilage, fat, fibrous connective tissue, and cells that support the formation of blood can also be isolated from bone marrow. Which is considered to be he most nutrient in the body of ASCs.

Focus Is On Cures

Regenerative medicine includes tissue engineering but also incorporates research on self-healing – where the body uses its own systems, sometimes with help foreign biological material to recreate cells and rebuild tissues and organs. The focus is on cures instead of treatments for complex, often chronic, diseases.

Stephen Hawking met with Mr. Deven Patel the CEO of San Diego based Global Institute of Stem Cell Therapy and Research (GIOSTAR) on Saturday to learn more about how soon stem cell research can help in his neurological disorder ALS (amyotrophic lateral sclerosis) that has left the famed British physicist completely paralyzed.

He was visiting San Diego to attend the private tree planting ceremony in memory of one of his oldest friends, the late San Diego philanthropist Dennis Avery.

Giostar CEO Mr. Deven Patel with Mr. Stephen Hawking

Dr. Hawking spent more than hour with Mr. Patel in private meeting to learn the recent development in the field of stem cells, specially related to ALS, the condition British Physicist was diagnosed for almost five decades ago. “Even after his long afternoon event, he was very attentive to my stem cell presentation,” said Mr. Patel.

He had so many questions in his mind and he was very encouraged with the progress of the stem cell science in the field of neurology. Mr. Patel has requested his staff for his medical history to be studied by GIOSTAR team of scientists and clinicians.

With the advancement of stem cell science, our range of interests at GIOSTAR is expanding every single day. While our therapeutic programs are focused exclusively on the transplantation of tissue-derived (adult) stem cells and progenitor cells for several degenerative diseases of different organs, we believe there is a utility in all types of stem cells and their progeny.

Today GIOSTAR scientists study all three types of stem cells: tissue-derived stem cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, as well as progenitor cells. Molecular biology, genetic engineering and protein chemistry are core technologies for conducting this research. We consider all of these cell types as viable options both as cell-based therapies and as tools and technologies for drug discovery and development.

To speed up the transition from research to treatment, GIOSTAR has collaborated with the government of India to bring its treatment for sickle cell anemia to three states in the country serving some 150 million people in the world’s largest stem cell treatment hospital setting of its kind! In 2011 GIOSTAR has also inaugurated one of the world’s first dedicated stem cell treatment hospital in Ahmedabad, India. The company is developing plans for similar facilities in California as well as China, Thailand, Philippines, Dubai, Brazil, Sweden, Bahamas and few more worldwide locations.

The Chairman of GIOSTAR Dr. Anand Srivastava said, with the rapid progress in the field of stem cell science, we are not that far from the cures for many devastating diseases that are considered incurable today. “And If we can cure great human being like Dr. Stephen Hawking, this world certainly will be a better place to live,” he said.

Amyotrophic lateral sclerosis is one of the most distressing neurodegenerative disorders, which is typified by gradual deterioration of motor neurons. This happens in the spinal cord, cortex, and the brainstem. As a result of this disorder, patients suffer from respiratory deficiency as well as paralysis, which ultimately prove fatal. Comprehending the causes of ALS makes the treatment of this disorder even more difficult. However, stem cell treatment has surfaced as a promising treatment of late. With ongoing research and development around the world ALS treatment India is also growing at a fast pace. India n hospitals and centers are also involved vigorously in research and development activities to make Stem Cell therapy more accessible.

There is huge potential of Stem Cell therapy in treating cardiovascular, neurological, as well as ocular disorders. Several clinical studies regarding ALS treatment India are being carried out with stress on autologous stem cells, progenitor and stem cells, and at the same time, researchers are also trying to maintain highest standards and ethical values to match the global standards.

In the recent times cases of Amyotrophic lateral sclerosis is on the rise, and many other diseases related to lifestyle is also increasing rapidly with rapid increase in the population. Along with ALS treatment India, many other therapies will be launched in the India n market in the next few years. Given that, stem cells comprise of the power to differentiate into a variety of cells, these put forward treatment options for a number of degenerative diseases and disorders. Other than treatment of Amyotrophic lateral sclerosis, Stem Cell therapy is also used in treating other motor neuron ailments such as spinal muscular atrophy, primary lateral sclerosis, progressive bulbar palsy, and progressive muscular atrophy. Motor neuron disorders like ALS reduce quality and span of life drastically, and stem cell transplantation has emerged as an ideal treatment.

This is Judy from the organizing committee of CMCB-2016. I have sent you an invitation letter concerning the oral presentation at this congress but unfortunately without hearing from you.

We are honored to announce that the 6th Annual World Congress of Molecular & Cell Biology (CMCB-2016) will be hold during April 25-28, 2016 in Dalian, China, with the theme “Unlocking the Secrets of Cells”. On behalf of the organizing committee, I am writing to you to propose a Speech on your recent research about Mesenchymal Stem Cells in Regenerative Medicine… for the Forum6-2: Tissue Repair & Regeneration. We believe that your participation will add great value for CMCB-2016. For more information, please visit the conference website at http://www.bitcongress.com/cmcb2016/.

CMCB successfully began with 2011, there were more than 200 participants from over 26 countries and areas have attended the CMCB-2011. Participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysis the development of Molecular & Cell Biology. The CMCB-2012, CMCB-2013 and CMCB-2014 had also been successfully held in Beijing, Suzhou and Dalian. CMCB-2015 was just held simultaneously with other 7 conferences in Nanjing. It was a grand meeting with thousands of people for science and technology, which absolutely brought us a big breakthrough. Depending on the warmly support and valuable suggestions from all of the participants, we are confident in organizing CMCB-2016.

Since cell and molecular biology have made tremendous strides over time, we aim to bring together biochemists, molecular biologists, cell and developmental biologists and other professionals, who are active in the field of molecular and cell biology, to present their exciting new findings in major plenary forum and in a wide array of more special sessions.

A rich selection of topics will be addressed during CMCB-2016, which includes:

Forum 1: Forefront in Cellular Structures, Functions and Events

Forum 2: Hot Stories of Stem Cells

Forum 3: New Ideas in Cell Energy and Metabolism

Forum 4: Cutting Edge Topics in RNA Biology

Forum 5: State-of-the-Art Technologies for Cell

Forum 6: Translational Molecular & Cell Biology

The program of CMCB is promised to be informative; it will foster the collaborations among professionals in China and beyond.

Dalian – China’s Best Tourist City. With beautiful scenery, a nice climate and fast development, this romantic city ranks among China’s best tourist destinations in many people’s minds. It is also a trading and financial center in northeastern Asia and has gained the name “Hong Kong of Northern China”. We hope you will enjoy the modern daily changing Dalian with the unforgettable memory in China.

If you have been to prior meetings, we warmly welcome your return as our regular friends. If this is your first meeting, we also welcome you to our “family” gathering.

Cranial reconstructions will soon be radicalized with the addition of 3D printing and stem cells into the method. A team of scientists from Western Australia will soon attempt this new technique with the intention of seeing the reduction in risk of complications, surgical procedure duration and costs.

The first patients will be those from the Royal Perth Hospital, whose skulls have either been severely damaged or partially removed for brain surgery.

The research team, which includes a surgeon, two engineers, a neurosurgeon and chief scientist will collaborate with a Vienna-based 3D printing firm to replicate the bones from the patients’ cranium.

A printed bioceramic scaffold less than 100 microns (0.1mm) of the original bone will be infused with millions of stem cells. This will be fitted onto the patient’s skull.

This is the first time stem cells will be put to use with 3D printed scaffold to assist in bone regrowth, according to neurosurgeon Marc Coughlan.

“What we’re trying to do is take it one step further and have the ceramic resorb and then be only left with the patient’s bone, which would be exactly the same as having the skull back,” he said.

Health minister Kim Hames says,”This project highlights some of the innovative and groundbreaking research that is under way in WA’s public health system, and the commitment of the government to supporting this crucial work.”

The reconstruction project is part of the nine health and medical projects in Western Australia that has been allocated A$2 Million (US$1.5 Million) research funding grant by the state government. The government’s aim is to eventually reduce costs and improve efficiency in Australia’s public health service through the help of these projects.

Previous methods by past studies had the bone part frozen and stored for later replanting. However, attempts to replant often resulted either in infection or bone resorption. The more popular titanium plates, on the other hand, pose the problem of eventual material degradation.